Preferences of Patients with Non-Communicable Diseases for Primary Healthcare Facilities: A Discrete Choice Experiment in Wuhan, China

International Journal of Environmental Research and Public Health
Erping JiaJuyang Xiong

Abstract

To elicit stated preferences of patients with non-communicable diseases (NCDs) for primary healthcare (PHC) facilities and to explore the willingness-to-pay (WTP) for facility attributes. A discrete choice experiment (DCE) was conducted through face to face interviews. The DCE survey was constructed by five attributes: type of service, treatment measures, cost, travel time, and care provider. Patients' preferences and willingness to pay for facility attributes were analyzed using a mixed logit model, and interaction terms were used to assess preference heterogeneity among patients with different sociodemographic characteristics. Patients placed different weights on attributes, depending on whether they perceived their health condition as minor or severe. For conditions perceived as minor, patients valued treatment measures (56.60%), travel time (32.34%) and care provider (8.51%) most. For conditions perceived as severe, they valued treatment measures (52.19%), care provider (38.69%), and type of service (7.30%) most. The WTP related to the change from Traditional Chinese Medicine (TCM) service to Modern Medicine (MM) service was the largest for both severity scenarios. For conditions perceived as minor, patients would be willin...Continue Reading

References

Jul 12, 1997·BMJ : British Medical Journal·D W Light
Jul 12, 1997·BMJ : British Medical Journal·T Hesketh, W X Zhu
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Apr 7, 2004·Health Economics·Mandy Ryan, Diane Skåtun
Apr 27, 2005·Health Economics·Mickael Bech, Dorte Gyrd-Hansen
Jan 25, 2007·Journal of Health Services Research & Policy·Joanna Coast, Sue Horrocks
Jan 30, 2007·Social Science & Medicine·Emily LancsarTerry Flynn
Jan 15, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E W de Bekker-GrobE W Steyerberg
Jul 16, 2008·PharmacoEconomics·Emily Lancsar, Jordan Louviere
May 12, 2009·Health Policy and Planning·Dongfu QianQingyue Meng
Jun 16, 2012·BMC Health Services Research·Paul Jacob RobynRainer Sauerborn
Apr 17, 2014·Vaccine·Kalpana ManthiramAreej Hassan
Sep 22, 2015·American Journal of Health Promotion : AJHP·Luciana TorquatiMichael Leveritt
Feb 6, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Axel C MühlbacherMatthias Nübling
Mar 10, 2016·Journal of the American Board of Family Medicine : JABFM·Dan Wu, Tai Pong Lam
Jun 22, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A Brett HauberJohn F P Bridges
Jun 20, 2017·Journal of Clinical Pharmacy and Therapeutics·M FeehanM A Munger
Jul 13, 2017·BMC Health Services Research·Kim-Sarah KleijChristian Krauth
Dec 13, 2017·Lancet·Xi LiShengshou Hu
Jul 4, 2019·Globalization and Health·Li WangJinxia Yang
Jul 26, 2019·Geriatrics & Gerontology International·Xiaoqian HuHengjin Dong
Aug 14, 2019·Social Science & Medicine·Yun LiuEsther W de Bekker-Grob
Feb 27, 2020·Journal of Medical Economics·Anne J M GoossensMickael Hiligsmann

❮ Previous
Next ❯

Citations

Sep 24, 2020·International Journal of Environmental Research and Public Health·Sabina De RosisFrancesca Pennucci

❮ Previous
Next ❯

Software Mentioned

Stata
SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.